CD4+ Memory T-Cell Formation during Type 1 Immune Responses
Author(s) -
P. Krueger,
Kevin C. Osum,
Marc K. Jenkins
Publication year - 2021
Publication title -
cold spring harbor perspectives in biology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.011
H-Index - 173
ISSN - 1943-0264
DOI - 10.1101/cshperspect.a038141
Subject(s) - effector , biology , microbiology and biotechnology , cytotoxic t cell , il 2 receptor , cd8 , natural killer t cell , interleukin 21 , antigen presenting cell , major histocompatibility complex , t cell , memory t cell , immune system , immunology , genetics , in vitro
Naive CD4 + T cells become memory cells after proliferating in response to their cognate major histocompatibility complex class II (MHCII)-bound peptide and passing through an effector cell stage. The process by which CD4 + memory T cells emerge from the effector cell pool, however, is less well understood than in the case of CD8 + T cells. During certain acute infections, naive CD4 + T cells proliferate and differentiate into various forms of type 1 (Th1) and follicular helper (Tfh) effector cells. We review the evidence that about 10% of the cells in each of these subsets survive to become memory cells that resemble their effector cell precursors. The roles that asymmetric cell division, the TCF-1 transcription factor, metabolic activity, reactive oxygen species, and the IL-7 receptor play in the effector to memory cell transition are discussed. We propose a speculative model in which the metabolic activity needed for rapid clonal expansion also generates toxic products that induce apoptosis in most effector cells. Memory cells then arise from the effector cells in each subset that are at the low end of the metabolic activity spectrum.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom